# Gsk (gsk.com): agent-readiness 83/100, grade B > Rank 9 of 1000 on Qomvia (rubric v2.3.0). Last scanned 2026-09-29T04:40:46.858Z. Page: https://qomvia.com/site/gsk-com JSON: https://qomvia.com/api/score/gsk-com ## Summary Category: Health and pharmacy { "known": true, "confidence": "high", "summary": "GSK (GlaxoSmithKline) is a global pharmaceutical and healthcare company. It focuses on the research, development, manufacturing, and marketing of innovative medicines, vaccines, and consumer healthcare products.", "offerings": [ "Prescription medicines", "Vaccines", "Over-the-counter (OTC) consumer health products", "Biologics", "Research and development services (indirectly)" ], "audience": "Patients, healthcare professionals, researchers, investors, and general consumers (for OTC products).", "geography": "Global", "strengths": [ "Established global presence and reputation", "Strong focus on scientific research and development in key disease areas", "Diverse portfolio of medicines, vaccines, and consumer health brands", "Significant contributions in areas like HIV, respiratory, and infectious diseases", "Commitment to innovation in healthcare solutions" ], "unknowns": [ "Specific details of current financial performance or market share by product", "Exact scope of ongoing clinical trials without external lookup", "Internal corporate culture or employee satisfaction metrics", "Detailed pricing strategies for specific medications", "Complete list of all ongoing R&D partnerships" ], "alternatives": [ "pfizer.com", "astrazeneca.com", "novartis.com", "merck.com", "sanofi.com" ], "business": "Global pharmaceutical and healthcare company that discovers, develops, manufactures, and markets innovative medicines, vaccines, and consumer healthcare products for patients and consumers worldwide.", "competitors": [ "pfizer.com", "astrazeneca.com", "novartis.com", "merck.com", "sanofi.com", "bms.com", "eli-lilly.com" ] } ## Score by group - Machine access: 24/24 - Content legibility: 23/26 - Discovery surface: 20/20 - Identity & policy: 3/12 - Agent-facing performance: 8/8 - Agent protocols: 5/10 Failing checks: - [blocker] The site does not say who it is - [improvement] No stated policy for automated access - [improvement] No Content Signals - [improvement] Content carries a date - [improvement] No Markdown for agents ## Add-on packs - E-commerce & product feeds: 36/100 (not part of the public score) ## AI mentions and rivals - pfizer.com: not measured - novartis.com: not measured - merck.com: not measured - sanofi.com: not measured - bms.com: not measured ## FAQ Q: Is Gsk readable by AI agents? A: Gsk (gsk.com) scores 83 out of 100 for agent readiness, grade B, measured yesterday, on 29.09.2026. 1 of 3 agent classes we test can use the site, and 1 check currently block agents outright. Q: What stops agents from using gsk.com? A: The heaviest problems are: The site does not say who it is; No stated policy for automated access; No Content Signals; Content carries a date; No Markdown for agents. Each one is scored from a public HTTP response, and the fix for each is listed in the signed-in report. Q: How is the Gsk agent-readiness score calculated? A: Qomvia fetches public pages of gsk.com as an AI agent would and runs the core checks every site gets across 6 groups: Machine access, Content legibility, Discovery surface, Identity & policy, Agent-facing performance, Agent protocols. Checks are weighted by how much an agent loses when they fail, and the score is expressed out of 100. E-commerce & product feeds checks are scored separately (36/100) and do not affect the public score or rank. Q: How often is this score updated? A: Public scores are re-checked when the site is re-scanned; tracked domains are re-scanned weekly and their owners are alerted when a check regresses. This page shows the scan from yesterday, on 29.09.2026. ## Related - Leaderboard: https://qomvia.com/leaderboard — category ranking: https://qomvia.com/leaderboard/health-pharmacy - Score another site: https://qomvia.com/